Category Archives: Industry

Industry news on LLLT, Low Level Laser Therapy, Cold Laser, Laser Biostimulation, LEPT Low Energy photon Therapy, LILT Low Intensity Laser therapy, Photobiomodulation, Photostimulation, Laser Therapy

Valeda Light Delivery System Receives 2019 Medical Design Excellence Award

SEATTLE, June 12, 2019 /PRNewswire/ — LumiThera, Inc. and Product Creation Studio today announced that LumiThera’s Valeda Light Delivery System has been honored with a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2019 in conjunction with the MD&M East event in New York, New York.

Valeda® Light Delivery System

LumiThera, Inc. is a leader in the use of photobiomodulation for the treatment of acute and chronic ocular diseases and disorders. Age-related macular degeneration (AMD) is the leading cause of blindness in adults over 65. … Continue reading

Posted in Industry | Leave a comment

Interview with James Carroll by Dr Hisham Abdalla

Dr Hisham Abdalla from Light Spa NZ interviews James Carroll CEO, Founder and Inventor of Thor Photomedicine and the NovoTHOR light-pod.

James Carroll shares visions, science, evolution and the future of PhotoBiomodulation and Light/laser therapies, as well as James’s recent achievements at the US Congress and The United Nations.

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, Video of the Week | Leave a comment

Podcast interview of James Carroll by Gut Check Project

“Photobiomodulation … If you’ve never heard of this well researched and incredible technology to decrease inflammation and shorten healing time, watch our Podcast Video! PBM has successfully helped thousands of people in over 70 countries with chronic pain, macular degeneration, shingles pain, recovery from athletic injury, CTE, PTSD and more. Check out ThorLaser.com to connect with James, his research, and how THOR PBM can improve your life.”

Gut Check Project
Kenneth Brown, MD
Board Certified Gastroenterologist

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, THE FUTURE OF LLLT, Video of the Week | Leave a comment

James Carroll’s Photobiomodulation and NovoTHOR interview

Laser Therapy Sydney interviews James Carroll CEO and Founder of Thor Photomedicine and the NovoTHOR light-pod.

James Carroll sheds light on what Photobiomodulation is and what conditions it can treat; who is using it and how Thor products are different; oral mucositis and the opioid crisis; and the future of PBM in Australia.

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, THE FUTURE OF LLLT, Video of the Week | Leave a comment

James Carroll’s Congress speech on ending opioid use with Photobiomodulation

A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in health care, direct health care costs and lost productivity because of pain.

49,000 people from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.

We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.

Learn more at CongressPBM.com

Watch the Congressional Briefing Highlight Video

Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com

View … Continue reading

Posted in Industry, THE FUTURE OF LLLT, Video of the Week | Leave a comment

LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration

LumiThera Inc., a commercial stage medical device company creating a photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it is a recipient of a small business innovative research (SBIR) phase II grant from the National Institute of Health (NIH) and the division of the National Eye Institute (NEI).

Valeda™ Light Delivery System patient treatmentThe phase II grant supports a prospective, randomized, multi-center human clinical trial in U.S. subjects diagnosed with dry age-related macular degeneration (dry AMD.) The LIGHTSITE III trial, which is subject to FDA Investigational Device Exemption (IDE) approval, will test vision and examine disease pathology in the … Continue reading

Posted in Industry | Leave a comment

Ending Opioids by Photobiomodulation

James Carroll, CEO and founder of THOR Photomedicine – Speech to Congress.

We are all aware there is an opioid crisis.

  • A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in direct health care costs and lost productivity because of pain.
  • 49,000 people died from opioids in 2017.
  • 19,000 of which were from prescribed opioids for pain relief.

We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.

Read the full Speech to Congress on Continue reading

Posted in Industry, THE FUTURE OF LLLT | 1 Comment